Media

Spruce Biosciences Appoints Mike Grey as Interim CEO

Jakob Lindberg appointed CEO of Oncopeptides

Carisma Therapeutics Presents Data from Phase I Clinical Trial of CT-0508, A HER2 Targeted CAR-Macrophage

Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights

Nordic Nanovector supports The Health Policy Partnership’s initiative to improve appropriate readiness for radioligand therapy (radioimmunotherapy) in lymphoma

Fusion Pharmaceuticals Announces Third Quarter 2021 Financial Results And Clinical Program Update

Aprea Therapeutics Reports Third Quarter 2021 Financial Results and Provides Update on Business Operations

Nordic Nanovector appoints experienced biotech executive Pierre Dodion MD as Chief Medical Officer

Aprea Therapeutics to Present Data from Clinical Trials Evaluating Eprenetapopt at 63rd American Society of Hematology Annual Meeting